A detailed history of Thrivent Financial For Lutherans transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 12,828 shares of ANIP stock, worth $743,254. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,828
Previous 13,028 1.54%
Holding current value
$743,254
Previous $777,000 8.75%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

SELL
$53.35 - $61.74 $10,670 - $12,348
-200 Reduced 1.54%
12,828 $709,000
Q3 2024

Nov 07, 2024

BUY
$54.33 - $65.72 $16,244 - $19,650
299 Added 2.35%
13,028 $777,000
Q2 2024

Aug 13, 2024

SELL
$58.53 - $68.82 $20,426 - $24,018
-349 Reduced 2.67%
12,729 $811,000
Q1 2024

May 14, 2024

SELL
$54.2 - $69.69 $19,295 - $24,809
-356 Reduced 2.65%
13,078 $904,000
Q4 2023

Feb 14, 2024

SELL
$48.72 - $65.43 $59,584 - $80,020
-1,223 Reduced 8.34%
13,434 $741,000
Q3 2023

Nov 14, 2023

BUY
$50.28 - $64.61 $67,224 - $86,383
1,337 Added 10.04%
14,657 $851,000
Q2 2023

Aug 14, 2023

BUY
$37.29 - $53.83 $45,195 - $65,241
1,212 Added 10.01%
13,320 $717,000
Q1 2023

May 17, 2023

SELL
$37.61 - $45.72 $15,946 - $19,385
-424 Reduced 3.38%
12,108 $481,000
Q4 2022

Feb 08, 2023

BUY
$31.9 - $41.95 $1,914 - $2,517
60 Added 0.48%
12,532 $504,000
Q3 2022

Nov 14, 2022

SELL
$29.83 - $38.01 $11,842 - $15,089
-397 Reduced 3.08%
12,472 $401,000
Q2 2022

Aug 16, 2022

BUY
$23.09 - $33.46 $57,978 - $84,018
2,511 Added 24.24%
12,869 $382,000
Q1 2022

May 13, 2022

BUY
$26.91 - $47.15 $41,710 - $73,082
1,550 Added 17.6%
10,358 $291,000
Q4 2021

Feb 16, 2022

BUY
$32.97 - $56.85 $32,112 - $55,371
974 Added 12.43%
8,808 $406,000
Q3 2021

Nov 15, 2021

SELL
$26.48 - $35.99 $7,493 - $10,185
-283 Reduced 3.49%
7,834 $257,000
Q2 2021

Aug 19, 2021

BUY
$31.86 - $38.6 $6,531 - $7,913
205 Added 2.59%
8,117 $284,000
Q1 2021

May 17, 2021

SELL
$28.4 - $36.14 $42,401 - $53,957
-1,493 Reduced 15.87%
7,912 $286,000
Q4 2020

Feb 16, 2021

BUY
$23.69 - $31.47 $34,540 - $45,883
1,458 Added 18.35%
9,405 $273,000
Q2 2020

Aug 12, 2020

BUY
$29.93 - $50.1 $4,519 - $7,565
151 Added 1.94%
7,947 $257,000
Q1 2020

May 15, 2020

BUY
$30.35 - $67.14 $11,836 - $26,184
390 Added 5.27%
7,796 $318,000
Q4 2019

Feb 13, 2020

BUY
$55.65 - $79.83 $1,057 - $1,516
19 Added 0.26%
7,406 $457,000
Q3 2019

Nov 14, 2019

BUY
$64.7 - $85.39 $56,871 - $75,057
879 Added 13.51%
7,387 $538,000
Q2 2019

Aug 13, 2019

BUY
$67.77 - $82.2 $12,334 - $14,960
182 Added 2.88%
6,508 $535,000
Q1 2019

May 14, 2019

BUY
$45.83 - $70.54 $21,769 - $33,506
475 Added 8.12%
6,326 $446,000
Q4 2018

Feb 15, 2019

SELL
$41.17 - $56.44 $20,585 - $28,220
-500 Reduced 7.87%
5,851 $263,000
Q3 2018

Nov 15, 2018

BUY
$52.95 - $71.34 $6,618 - $8,917
125 Added 2.01%
6,351 $359,000
Q2 2018

Aug 14, 2018

BUY
$56.38 - $68.08 $24,187 - $29,206
429 Added 7.4%
6,226 $416,000
Q1 2018

May 08, 2018

BUY
$56.98 - $72.41 $10,598 - $13,468
186 Added 3.31%
5,797 $338,000
Q4 2017

Feb 14, 2018

BUY
$53.3 - $74.56 $5,916 - $8,276
111 Added 2.02%
5,611 $362,000
Q3 2017

Nov 14, 2017

BUY
$43.46 - $52.49 $239,030 - $288,695
5,500
5,500 $289,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.01B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.